Different Mechanisms for the Progression of CKD with ACE Gene Polymorphisms

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Nephron Clinical Practice

• Publication date

  2009-03-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000209150PMID 19293592
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Renin-Angiotensin-Aldosterone System Triple Blockade on Non-Diabetic Renal Disease: Addition of an Aldosterone Blocker, Spironolactone, to Combination Treatment with an Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker

  2008cited by this paper
• Low-responders to angiotensin II receptor blockers and genetic polymorphism in angiotensin-converting enzyme.

  2007cited by this paper
• Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial

  2007cited by this paper
• Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy.

  2006cited by this paper
• Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-- interaction with ACE insertion/deletion polymorphism.

  2006cited by this paper
• Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy?

  2006cited by this paper
• Beneficial impact on cardiovascular risk factors by dual blockade of the renin-angiotensin system in diabetic nephropathy.

  2004cited by this paper
• Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.

  2003cited by this paper
• Renoprotective efficacy of renin–angiotensin inhibitors in IgA nephropathy is influenced by ACE A2350G polymorphism

  2003cited by this paper
• Angiotensin-converting enzyme inhibitor withdrawal and ACE gene polymorphism.

  2003cited by this paper
• Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy.

  2003cited by this paper
• Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy.

  2003cited by this paper
• Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy.

  2003cited by this paper
• Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy?

  2002cited by this paper
• Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy.

  2002cited by this paper
• Progression, remission, regression of chronic renal diseases.

  2001cited by this paper
• Influence of insertion/deletion polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type 1 diabetic patients with microalbuminuria.

  2000cited by this paper
• Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy.

  1998cited by this paper
• Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis.

  1998cited by this paper
• Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM.

  1998cited by this paper
• The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

  1994cited by this paper
• The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.

  1994cited by this paper

• The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level

  2022cites this paper
• Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients

  2017cites this paper
• Association between the I/D polymorphism of the ACE gene and the development of asphyxia in newborns

  2016cites this paper
• Gene Polymorphisms of Adducin GLY460TRP, ACE I/D, and AGT M235T in Pediatric Hypertension Patients

  2014cites this paper
• Clinical impact of an angiotensin I-converting enzyme insertion/deletion and kinin B2 receptor +9/-9 polymorphisms in the prognosis of renal transplantation

  2013cites this paper
• ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy.

  2012cites this paper
• Angiotensin II Type 1 Receptor Gene Polymorphism in Egyptian Patients with Chronic Renal Failure

  2012cites this paper
• Genetic studies in chronic kidney disease: basic concepts.

  2012cites this paper
• Detection Of Angiotensin Converting Enzyme Gene Polymorphism In Egyptian Patients With Diabetic Nephropathy

  2011cites this paper
• Genetic polymorphism of ACE and the angiotensin II type1 receptor genes in children with chronic kidney disease

  2011influential citation
• Implications of the angiotensin converting enzyme gene insertion/deletion polymorphism in health and disease: a snapshot review.

  2010cites this paper